APA (7th ed.) Citation

R, G., A, P., C, C., MZ, W., AP, C., YX, L., . . . KH, Y. (2025). The effect of sodium-glucose cotransporter 2 inhibitors on HbA1c variability and cardiovascular and renal adverse outcome in patients with T2DM. Diabetes, obesity & metabolism, 27(9), 4720. https://doi.org/10.1111/dom.16509

Chicago Style (17th ed.) Citation

R, Guo, et al. "The Effect of Sodium-glucose Cotransporter 2 Inhibitors on HbA1c Variability and Cardiovascular and Renal Adverse Outcome in Patients with T2DM." Diabetes, Obesity & Metabolism 27, no. 9 (2025): 4720. https://doi.org/10.1111/dom.16509.

MLA (9th ed.) Citation

R, Guo, et al. "The Effect of Sodium-glucose Cotransporter 2 Inhibitors on HbA1c Variability and Cardiovascular and Renal Adverse Outcome in Patients with T2DM." Diabetes, Obesity & Metabolism, vol. 27, no. 9, 2025, p. 4720, https://doi.org/10.1111/dom.16509.